# Novel peptide strategy enhances precision in cancer targeting Acidity-activated peptides could revolutionize tumor-specific drug delivery. - **Source:** [Phys.org - latest science and technology news stories](https://brifing.si/source/8b0f98da-d179-4c93-871f-7ac460bf9c61) - **Published:** 2026-07-21 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/5c0e749c-0ac1-45b7-a165-c83239d541bf ## Next-Gen Cancer Therapies Researchers at the University of Tennessee are developing smart peptides that activate in acidic tumor microenvironments. This innovative approach aims to target cancer cells precisely while sparing healthy tissues. ## pH-Sensitive Mechanism Francisco N. Barrera's lab engineered special peptides responsive to pH changes. These molecules remain inert in normal tissues but penetrate cell membranes exclusively in low-pH tumor conditions. ## Targeted Treatment Benefits Unlike conventional chemotherapy, this method could significantly reduce side effects. The selective activation ensures drugs only become active in cancerous regions. ## Biochemical Innovation The team structurally modified peptides to acquire acid-sensing capabilities. These molecules can recognize tumor-specific biochemical signals with remarkable precision. ## Preclinical Potential While still in lab stages, the approach shows promising results in animal models. Researchers are preparing to advance toward human trials. ## New Oncology Paradigm If successful, this technology could usher in a new era of cancer treatment. The study represents a significant leap in personalized medicine, potentially increasing efficacy while minimizing adverse effects. ## Sources covering this story - https://phys.org/news/2026-07-peptide-strategy-aims-cancer-precise.html — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._